Kyverna Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| KYTX | 2126.HK | NKTX | CABA | ALLO | 24H.F | |
|---|---|---|---|---|---|---|
| Market cap | 319.11M | 1.11B | 123.91M | 240.75M | 411.13M | 352.86M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.6 | -3.0 | -1.0 | -1.2 | -1.9 | — |
| Price/book | 1.9 | 2.0 | 0.5 | 1.1 | 0.9 | -0.5 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −27.22% | −31.72% | −12.18% | −42.74% | +13.33% | +37.87% |
| Today | 0.00% | +7.91% | +13.07% | 0.00% | +6.25% | −0.23% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All KYTX news ›Kyverna Therapeutics, Inc. (KYTX) – What Are Analysts Saying About This Stock?
Posted by Danessa Lincoln on Nov 4th, 2026 Read Our Latest Report on KYTX Shares of KYTX stock opened at $5.16 on Wednesday. The company has a current ratio of 9.06, a quick ratio of 9.06 and a debt-to-equity ratio of 0.15. Kyverna…
Kailera Therapeutics to Participate in November Investor Conferences
Rising Dragon Acquisition Corp. and HZJL Cayman Limited Announce Mutual Termination of Merger Agreement Shopify Sustains Rapid Growth with Revenue Up 32% and Free Cash Flow Margin of 22% Robo.ai Subsidiary Neurovia AI Highlights…
Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. EMERYVILLE, Calif., and WALTHAM, Mass., July 27, 2026 ...
Kyverna Therapeutics Presents Full One-Year Registrational Data Set Demonstrating Sustained ...
Miv-cel reversed disability and achieved durable efficacy across all primary and secondary endpoints through one year, with nearly all patients remaining off chronic immunotherapies Deep B-cell depletion demonstrated with a single dose…
Transcript : Kyverna Therapeutics, Inc. - Special Call
Presentation Operator MessageOperator Thanks. Good morning, and welcome to the Kyverna Therapeutics Conference Call. [Operator Instructions] Please note, this call is being recorded. I would now Transcript : Kyverna Therapeutics, Inc. -…
Kyverna Therapeutics, Inc. Amends Loan And Security Agreement To Extend Availability Of Term A Loans
Kyverna Therapeutics, Inc. had previously disclosed that on October 31, 2025, it entered into that certain Loan and Security Agreement with Oxford Finance LLC, as collateral agent, and certain lenders...
Kyverna Therapeutics, Inc.: Relative Strength Chart - Stock Nasdaq
Compare Kyverna Therapeutics, Inc. with the company of your choice via a Relative Strength chart. Real-time KYTX price, Nasdaq stock exchange Relative Strength Chart Kyverna Therapeutics, Inc. Biotechnology & Medical Research All financial…
Kyverna Therapeutics: Fascinating CAR-T Science, Tricky Commercial Outlook
Kyverna Therapeutics advances Miv-cel for autoimmune diseases, but valuation, launch, and funding risks remain. Click here to read this analysis on KYTX. - Kyverna is advancing Miv-cel, a CAR-T therapy for autoimmune diseases, with…
Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026
Broadcom to Advance NTT DOCOMO’s Private Cloud with VMware Cloud Foundation Grupo Aeroportuario del Pacifico Announces Results for the Third Quarter of 2026 e.l.f. Cosmetics Welcomes Kuromi™ to Glow Up! for Her First-Ever Roblox…
Kyverna Therapeutics: AIGH reports 5.9% stake
A passive stake tops 5% at Kyverna Therapeutics (KYTX) in a joint ownership report. Stock Titan - [SCHEDULE 13G] Kyverna Therapeutics, Inc. Passive Investment Disclosure (>5%) Kyverna Therapeutics: AIGH reports 5.9% stake The reported 5.9%…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- markets.businessinsider.com5
- marketscreener.com4
- stocktitan.net3
- defenseworld.net1
- marketbeat.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 17 articles, not a forecast.